Management of HIV/AIDS Press Release

Title Picture
08/15/2018 - 16:30
ViiV Healthcare reports positive 48-week results for first pivotal, phase III study for novel, long-acting, injectable HIV-treatment regimen
GlaxoSmithKline's picture
GlaxoSmithKline
08/15/2018 - 01:02
New HIV therapy reduces virus, boosts immunity in drug-resistant patients
YaleUniversity's picture
YaleUniversity
08/13/2018 - 17:09
Brief interventions during routine care reduce alcohol use among men with HIV
BrownUniversity's picture
BrownUniversity
08/06/2018 - 21:31
Balzer, International Team Lead Community-Based HIV Trial in East Africa
University of Massachusetts Amherst's picture
University of M...
07/26/2018 - 18:57
No coercion in treatment options for women living with HIV
IPPF's picture
IPPF
07/25/2018 - 12:04
Multi-disease health fairs, universal test and treat help East African communities achieve HIV benchmarks
NIH's picture
NIH
07/24/2018 - 17:05
Merck Announces Week 96 Data from Pivotal Phase 3 DRIVE-FORWARD Study of Its Investigational HIV Therapy Doravirine
Merck's picture
Merck
07/24/2018 - 15:30
Janssen Presents Switch Data for New HIV-1 Treatment SYMTUZA (D/C/F/TAF) and Second Study Supporting its Use in a Rapid Initiation Scenario
Johnson and Johnson's picture
Johnson and Johnson
07/24/2018 - 15:22
Janssen announces JULUCA (dolutegravir/rilpivirine) maintains viral suppression with two drugs in a once-daily, single-pill
Johnson and Johnson's picture
Johnson and Johnson
07/24/2018 - 12:09
ViiV Healthcare announces SWORD 100-week data for Juluca (dolutegravir/rilpivirine) at AIDS 2018
GlaxoSmithKline's picture
GlaxoSmithKline
07/23/2018 - 09:32
EGPAF Statement on Guidance Regarding Use of Dolutegravir by Pregnant Women
Ped AIDS's picture
Ped AIDS
07/17/2018 - 13:54
Janssen Announces U.S. FDA Approval of SYMTUZATM (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection
Johnson and Johnson's picture
Johnson and Johnson
07/02/2018 - 04:46
Merck to Present New Data from Studies of Investigational HIV Therapy Doravirine, Including Pivotal DRIVE-FORWARD Trial, at AIDS 2018
Merck's picture
Merck
06/27/2018 - 15:48
HIV Test and Treat pilot project in Yambio comes to a close
MSF's picture
MSF
06/26/2018 - 20:20
Department of Health Services Promotes Awareness on National HIV Testing Day
DHS Wisconsin's picture
DHS Wisconsin
06/13/2018 - 22:11
ViiV Healthcare reports landmark phase III studies for dolutegravir and lamivudine, demonstrating the ability to control HIV with a two-drug regimen in treatment naive patients
GlaxoSmithKline's picture
GlaxoSmithKline
06/13/2018 - 13:17
CSUN Prof Receives $435,000 Federal Grant to Study Ways to Improve the Health of Those Who Are HIV+
California State University Northridge's picture
California Stat...
06/11/2018 - 15:50
Many at risk for HIV despite lifesaving pill
University of Michigan's picture
University of M...
05/31/2018 - 09:07
Discovery reveals how cells try to control levels of key HIV protein
Salk Institute's picture
Salk Institute
05/21/2018 - 08:51
Janssen Announces European Commission Approval of JULUCA (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-1
Johnson and Johnson's picture
Johnson and Johnson
05/21/2018 - 04:41
ViiV Healthcare receives EU marketing authorisation for Juluca (dolutegravir/rilpivirine), the first 2-drug regimen, once-daily, single-pill for the treatment of HIV
GlaxoSmithKline's picture
GlaxoSmithKline
05/17/2018 - 07:44
Nearly half of women with HIV lack support to manage menopause
UniversityCollegeLondon's picture
UniversityColle...
05/07/2018 - 06:27
NIH clinical trial to track outcomes of kidney transplantation from HIV-positive donors to HIV-positive recipients
NIH's picture
NIH
04/18/2018 - 12:40
Top HIV Cure Research Team Refutes Major Recent Results on How to Identify HIV Persistence
Wistar Institute's picture
Wistar Institute
04/09/2018 - 11:54
Three Faculty Members Named Elite Medical and Biological Engineering Fellows
Northwestern University's picture
Northwestern Un...
03/28/2018 - 06:14
Mylan Introduces Symfi Triple Combo Once-Daily HIV Treatment in the U.S.
Mylan's picture
Mylan
03/23/2018 - 04:10
ViiV Healthcare gains CHMP positive opinion for Juluca (dolutegravir/rilpivirine) in Europe
GlaxoSmithKline's picture
GlaxoSmithKline
03/06/2018 - 16:02
Novel Population Council HIV and STI Prevention Research Presented at CROI, Worlds Preeminent HIV Research Meeting
Population Council's picture
Population Council
03/06/2018 - 10:18
FDA approves new HIV treatment for patients who have limited treatment options
FDA's picture
FDA
03/05/2018 - 13:02
ViiV Healthcare announces positive new dolutegravir data for the treatment of people living with HIV co-infected with tuberculosis
GlaxoSmithKline's picture
GlaxoSmithKline
03/05/2018 - 05:41
Broadly neutralizing antibody treatment may target viral reservoir in monkeys
NIH's picture
NIH
03/02/2018 - 10:04
Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.
Mylan's picture
Mylan
03/01/2018 - 09:22
Merck to Present New Data from Studies of Investigational HIV Therapies Doravirine and MK-8591 at CROI 2018
Merck's picture
Merck
02/19/2018 - 13:01
Center for HIV Cure Research
Gladstone Institutes's picture
Gladstone Institutes
02/01/2018 - 07:04
Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva Tablets
Mylan's picture
Mylan
01/24/2018 - 01:04
NIH begins large HIV treatment study in pregnant women
NIH's picture
NIH
12/27/2017 - 08:06
Teva Announces Exclusive Launch of a Generic Version of Reyataz in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
12/12/2017 - 21:19
Social stigma obstacle to successful treatment of children with HIV in Ethiopia
LundUniv's picture
LundUniv
12/01/2017 - 14:00
Patients with HIV-Associated Lymphoma Can Safely Continue Anti-Retroviral Therapy During Chemotherapy
Fox Chase's picture
Fox Chase
12/01/2017 - 11:24
Ukraine: People co-infected with HIV to receive hepatitis C treatment in Mykolaiv region
MSF's picture
MSF
12/01/2017 - 10:09
Rising levels of HIV drug resistance
UniversityCollegeLondon's picture
UniversityColle...
12/01/2017 - 09:39
Progress in Pursuit of a Cure - World AIDS Day 2017
PAREXEL's picture
PAREXEL
11/29/2017 - 17:59
Merck Receives FDA Approval for ISENTRESS (raltegravir), in Combination with Other Antiretroviral Agents, for the Treatment of HIV-1 Infection in Newborns Weighing at Least 2 kg
Merck's picture
Merck
11/27/2017 - 11:32
ViiV Healthcare starts third phase III HIV treatment study investigating long-acting two-drug regimen of cabotegravir plus rilpivirine
GlaxoSmithKline's picture
GlaxoSmithKline
11/21/2017 - 15:23
FDA approves first two-drug regimen for certain patients with HIV
FDA's picture
FDA
11/21/2017 - 02:23
Juluca (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill - a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection
GlaxoSmithKline's picture
GlaxoSmithKline
11/20/2017 - 01:51
UA Collaboration Focuses Attention on Emergency HIV Patients
ArizonaUniv's picture
ArizonaUniv
10/27/2017 - 02:53
ViiV Healthcare announces positive phase 3 results from the BRIGHTE study of fostemsavir in heavily treatment-experienced patients with HIV
GlaxoSmithKline's picture
GlaxoSmithKline
10/20/2017 - 12:42
HIV Patients Can Control the Virus, but Theyre Still Hoping for a Cure
Gladstone Institutes's picture
Gladstone Institutes
10/17/2017 - 10:55
New Research Opens the Door to Functional Cure for HIV
Scripps Research's picture
Scripps Research
10/05/2017 - 12:40
Researchers create molecule that could kick and kill HIV
UCLA's picture
UCLA
10/04/2017 - 15:18
Janssen Submits New Drug Application to U.S. Food and Drug Administration for the First Darunavir-Based Single Tablet Regimen for the Treatment of HIV-1
Johnson and Johnson's picture
Johnson and Johnson
09/28/2017 - 11:03
Indonesian prisoners with HIV getting aid from UIC researchers
UICUniv's picture
UICUniv
09/20/2017 - 10:33
Study will examine role of resilience among African Americans living with HIV
BrownUniversity's picture
BrownUniversity
08/07/2017 - 21:51
Mylan Launches Avonza in India
Mylan's picture
Mylan
08/07/2017 - 03:54
Mylan Receives Tentative Approval for "TLD" Under PEPFAR
Mylan's picture
Mylan
07/25/2017 - 09:48
ViiV Healthcare announces superior efficacy of dolutegravir versus lopinavir/ritonavir in second-line HIV treatment in resource-limited settings
GlaxoSmithKline's picture
GlaxoSmithKline
07/25/2017 - 09:05
Switching to a dolutegravir regimen from a boosted protease inhibitor regimen maintained viral suppression and improved lipid fractions in patients with HIV and high cardiovascular risk
GlaxoSmithKline's picture
GlaxoSmithKline
07/25/2017 - 05:56
Mercks Investigational NNRTI, Doravirine, Meets Primary Efficacy Endpoint of Non-Inferiority to Efavirenz, Both in Combination with Other Antiretroviral Agents, in Pivotal Phase 3 Trial for Treatment of HIV-1 Infection
Merck's picture
Merck
07/24/2017 - 05:24
Phase II study results showed comparable viral suppression rates at 96 weeks for a two-drug regimen of long-acting cabotegravir and rilpivirine and a three-drug regimen in patients with HIV
GlaxoSmithKline's picture
GlaxoSmithKline